10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,278,309 | -26.6% | 127,959 | -0.7% | 0.11% | -26.2% |
| Q2 2023 | $7,195,040 | +0.3% | 128,851 | +0.2% | 0.14% | -12.7% |
| Q1 2023 | $7,171,637 | +53.1% | 128,547 | +0.0% | 0.17% | +26.7% |
| Q4 2022 | $4,684,180 | +57.0% | 128,545 | +22.7% | 0.13% | +59.8% |
| Q3 2022 | $2,983,000 | -6.0% | 104,732 | +49.3% | 0.08% | -14.6% |
| Q2 2022 | $3,175,000 | -39.2% | 70,157 | +2.2% | 0.10% | -22.6% |
| Q1 2022 | $5,223,000 | -24.8% | 68,658 | +47.3% | 0.12% | -23.0% |
| Q4 2021 | $6,945,000 | +33.6% | 46,622 | +30.6% | 0.16% | +16.7% |
| Q3 2021 | $5,197,000 | -24.1% | 35,692 | +2.1% | 0.14% | -31.3% |
| Q2 2021 | $6,847,000 | +770.0% | 34,967 | +704.4% | 0.20% | +509.1% |
| Q1 2021 | $787,000 | +174.2% | 4,347 | +88.7% | 0.03% | +120.0% |
| Q3 2020 | $287,000 | – | 2,304 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |